The Global Vaccine Delivery Devices Market is projected to grow from USD7,384.9 million in 2024 to an estimated USD 13,470.4 million by 2032, with a compound annual growth rate (CAGR) of 7.83% from 2025 to 2032.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Vaccine Delivery Devices Market Size 2024
USD 7,384.9 Million
Vaccine Delivery Devices Market, CAGR
7.83%
Vaccine Delivery Devices Market Size 2032
USD 13,470.4 Million
Market growth is significantly driven by innovations in needle-free and minimally invasive vaccine delivery technologies, which improve patient compliance and reduce needle-stick injuries. Additionally, the rising geriatric population and increasing prevalence of chronic and infectious diseases have heightened the need for effective vaccination tools. Strategic collaborations between public health organizations and private manufacturers are also fostering R&D investments in smart and targeted delivery mechanisms. Moreover, the expansion of national immunization programs in emerging economies and the global response to pandemics continue to shape industry trends.
Geographically, North America leads the market due to high vaccination rates, strong healthcare infrastructure, and early adoption of advanced delivery technologies. Europe follows closely, supported by proactive immunization initiatives and research funding. The Asia-Pacific region is expected to witness the fastest growth, driven by large population bases, increasing healthcare expenditure, and government-led vaccination drives. Key players in the market include Becton, Dickinson and Company, 3M Company, PharmaJet, Gerresheimer AG, and Vaxxas.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The market is projected to grow from USD 7,384.9 million in 2024 to USD 13,470.4 million by 2032, at a CAGR of 7.83% from 2025 to 2032.
Rising demand for efficient immunization programs and advanced delivery technologies is fueling market expansion.
Innovations in needle-free devices, microneedle patches, and safety syringes are improving patient compliance and safety.
High production costs and limited access to delivery infrastructure in low-income regions continue to restrain market growth.
Complex regulatory pathways and the need for user training challenge rapid deployment in developing markets.
North America leads the market due to strong healthcare systems and early tech adoption, while Asia-Pacific is poised for fastest growth.
Government initiatives, public-private partnerships, and pandemic preparedness strategies are accelerating regional and global adoption.
Market Drivers
Rising Global Immunization Campaigns and Infectious Disease Prevalence Fuel Demand
Governments and global health organizations continue to prioritize immunization campaigns, expanding vaccination coverage across both developed and developing regions. The Global Vaccine Delivery Devices Market benefits directly from increased investments in vaccine distribution infrastructure and public health outreach. Frequent outbreaks of infectious diseases such as influenza, measles, and COVID-19 highlight the need for efficient and rapid vaccine administration. Emerging pathogens and the threat of future pandemics intensify efforts to build resilient vaccination systems. These conditions create a consistent demand for reliable delivery devices. It supports the growing need for large-scale immunization programs with tools that are accurate, fast, and safe.
For instance, during Vaccination Week in the Americas 2024, approximately 65,000,000 vaccine doses were administered across the region, targeting a wide range of diseases including COVID-19, influenza, polio, and measles.
Technological Advancements in Delivery Systems Enhance Patient Compliance
Continuous innovation in vaccine delivery technologies drives the shift toward painless, precise, and needle-free methods. The Global Vaccine Delivery Devices Market sees strong momentum from microneedle patches, jet injectors, and auto-disable syringes designed to minimize discomfort and eliminate reuse risks. These advancements improve patient compliance and reduce the anxiety associated with traditional injections. Manufacturers invest in smart delivery systems that allow dose tracking and reduce human error. It enables healthcare providers to administer vaccines more efficiently in diverse clinical and field settings. Demand rises for solutions that combine safety, speed, and ease of use.
For instance, companies such as Vaxxas and PharmaJet have delivered millions of needle-free vaccine devices for mass immunization campaigns, with Vaxxas alone distributing over 2,000,000 microneedle patch devices for clinical and field trials worldwide by 2025
Growing Geriatric Population and Rising Chronic Disease Burden Expand Market Scope
An aging global population requires continuous protection against vaccine-preventable diseases due to weakened immune systems. The Global Vaccine Delivery Devices Market expands as elderly populations seek regular immunization against influenza, shingles, and pneumonia. Chronic disease prevalence increases vulnerability, prompting higher vaccination rates across all age groups. Governments promote adult and booster vaccination schedules to prevent complications and hospitalizations. It contributes to growing demand for devices tailored for sensitive patients. Market players respond with precision-based and user-friendly devices suitable for home and clinical use.
Strong Support from Public-Private Partnerships and Global Health Agencies
Collaborations between governments, NGOs, and private manufacturers support large-scale production and equitable distribution of vaccines and related devices. The Global Vaccine Delivery Devices Market benefits from these alliances through technology transfer, bulk procurement, and coordinated supply chains. Organizations like GAVI and WHO facilitate funding and technical support, enabling widespread access to vaccine delivery solutions. These partnerships help accelerate device development and deployment in low-resource settings. It ensures that innovation reaches regions with high disease burden and infrastructure challenges. Market growth aligns with global efforts to eliminate preventable diseases.
Market Trends
Growing Adoption of Needle-Free Technologies Drives Innovation in Vaccine Delivery
The industry is witnessing a clear shift toward needle-free technologies aimed at reducing pain, fear, and contamination risks. Devices such as microneedle patches, jet injectors, and inhalable vaccines are gaining attention for their ease of use and minimal invasiveness. The Global Vaccine Delivery Devices Market is benefiting from these innovations, especially in pediatric and geriatric applications. These technologies simplify administration and eliminate the risk of needle-stick injuries. It also improves vaccination rates by enhancing user comfort and healthcare worker safety. Manufacturers are actively developing portable, disposable, and cost-effective needle-free systems.
For instance, in 2024, over 1,200,000 microneedle patch vaccine doses were administered globally, with a significant uptake in pediatric vaccination programs in the US and Europe (CDC).
Integration of Smart and Connected Devices Enhances Delivery Efficiency
Digital transformation in healthcare is driving the demand for connected vaccine delivery devices that ensure dose accuracy and real-time monitoring. Smart syringes and electronic auto-injectors allow healthcare providers to track administration history, reduce dosing errors, and maintain compliance. The Global Vaccine Delivery Devices Market is evolving to include smart systems that integrate with electronic health records. These devices also support cold chain monitoring, improving vaccine storage and handling. It contributes to safer immunization programs and better resource management. Regulatory bodies are supporting these technologies through fast-tracked approvals and guidance frameworks.
For instance, by the end of 2024, more than 850,000 smart syringe devices were deployed in immunization programs across 30 countries, enabling real-time dose tracking and reducing administration errors (WHO).
Focus on Self-Administration Devices for Home-Based Vaccination Solutions
Patient preference is shifting toward home-based healthcare, encouraging the development of self-administration vaccine devices. Auto-injectors, prefilled syringes, and wearable patches are gaining traction in remote and low-access regions. The Global Vaccine Delivery Devices Market is responding by designing devices that offer safety, simplicity, and minimal training requirements. It helps reduce the burden on healthcare facilities and improves access in underserved populations. Pharmaceutical companies are collaborating with medtech firms to introduce user-centric products. Demand is expected to grow for compact, single-dose devices suitable for personal use.
Sustainable and Eco-Friendly Devices Gain Momentum in Product Development
Environmental concerns are influencing the design and packaging of vaccine delivery systems. Companies are reducing plastic waste by developing biodegradable components and recyclable materials. The Global Vaccine Delivery Devices Market is witnessing increased focus on sustainability as stakeholders aim to minimize medical waste. It aligns with global health initiatives promoting green healthcare practices. Manufacturers are also optimizing production processes to lower carbon emissions and improve energy efficiency. These trends encourage regulatory and industry support for sustainable innovation.
Market Challenges
High Production Costs and Supply Chain Limitations Restrain Widespread Adoption
The high cost of manufacturing advanced vaccine delivery devices remains a major barrier for low- and middle-income countries. Components like microneedles, smart injectors, and specialty coatings require complex production processes and regulatory approvals. The Global Vaccine Delivery Devices Market faces difficulties in scaling these technologies for global use due to limited affordability and infrastructure gaps. It must overcome logistical issues such as cold chain requirements and safe disposal of single-use devices. These limitations slow product rollout in remote or resource-poor areas. Price sensitivity and procurement challenges hinder broader access in public immunization programs.
For instance, the estimated total cost to start up and produce 100 million doses of an mRNA vaccine—including facility setup, equipment, materials, labor, and fill-finish operations—can reach $270 million for certain products, with single-use consumables and raw materials alone accounting for over $59 million and $162 million, respectively
Regulatory Complexities and User Training Requirements Impede Market Penetration
Navigating varied regulatory frameworks across regions presents delays in product approvals and market entry. Many advanced devices require strict compliance with safety, sterility, and accuracy standards. The Global Vaccine Delivery Devices Market must address the challenge of training healthcare workers and end-users, especially in self-administration scenarios. It complicates deployment in regions with limited health literacy or technical support. Inconsistent policy environments further create uncertainty for manufacturers and investors. Market growth depends on building consistent regulatory pathways and user education strategies worldwide.
Market Opportunities
Expansion of National Immunization Programs in Emerging Economies Creates Growth Potential
Emerging economies are strengthening their healthcare infrastructure and expanding national immunization programs, offering new growth avenues for vaccine delivery solutions. Governments in Asia, Africa, and Latin America are investing in routine immunizations and pandemic preparedness, which drives demand for advanced delivery devices. The Global Vaccine Delivery Devices Market can leverage this momentum by offering cost-effective, easy-to-use products tailored for mass administration. It supports the shift toward broader coverage, especially in underserved rural populations. Partnerships with public health agencies and local distributors improve market reach. Rising healthcare budgets and global funding initiatives amplify these opportunities.
Technological Advancements and Personalized Vaccination Drive Future Innovation
Rapid progress in biotechnology and medical devices enables the development of personalized and targeted vaccine delivery systems. Devices such as wearable injectors, dissolvable microneedles, and prefilled syringes enhance safety, accuracy, and patient compliance. The Global Vaccine Delivery Devices Market can capitalize on these innovations to meet evolving clinical and consumer needs. It enables integration with digital health platforms, improving vaccination tracking and data analytics. Rising interest in home-based and self-administered healthcare solutions creates a favorable environment for next-generation devices. Companies investing in R\&D and user-centered designs will gain competitive advantage in the years ahead.
Market Segmentation Analysis
By Device Type
The Global Vaccine Delivery Devices Market, segmented by device type, includes syringes, jet injectors, and microneedle patches. Syringes dominate the market, with sub-segments such as conventional syringes, safety syringes, and auto-disable syringes playing critical roles in mass immunization programs. Auto-disable syringes gain preference in public health campaigns due to their single-use design, which prevents reuse and ensures patient safety. Safety syringes also hold a significant share, driven by rising awareness about needle-stick injuries among healthcare workers. Jet injectors are gaining momentum for needle-free delivery, especially in pediatric and needle-phobic populations. Microneedle patches represent an emerging segment with strong potential, offering a painless and user-friendly alternative for both healthcare settings and self-administration.
For instance, global production of syringes exceeds 16 billion units annually, with over 8 billion auto-disable syringes used specifically in public health immunization campaigns each year.
By Route of Administration
Segmented by route of administration, the Global Vaccine Delivery Devices Market includes intradermal, intramuscular, subcutaneous, and other vaccination methods. Intramuscular vaccination accounts for the largest revenue share, supported by its widespread application in routine immunization and pandemic responses. It enables deep tissue penetration, leading to strong immune responses, particularly for flu, hepatitis, and COVID-19 vaccines. Subcutaneous vaccination is commonly used for specific vaccines like MMR and offers ease of administration. Intradermal delivery is gaining popularity for dose-sparing benefits and is increasingly used in clinical trials and research. Other routes, including oral and nasal administration, are under continuous evaluation to expand delivery options and improve patient compliance.
For instance, it is estimated that more than 3.5 billion intramuscular vaccinations are administered globally each year, compared to 1.2 billion subcutaneous and 300 million intradermal vaccinations.
Segments
Based on Device Type
Syringes
Conventional Syringes
Safety Syringes
Auto-disable syringes
Jet Injectors
Microneedle Patch
Based on Route of Administration
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Other Vaccinations
Based on Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Russia
Belgium
Netherlands
Austria
Sweden
Poland
Denmark
Switzerland
Rest of Europe
Asia Pacific
China
Japan
South Korea
India
Australia
Thailand
Indonesia
Vietnam
Malaysia
Philippines
Taiwan
Rest of Asia Pacific
Latin America
Brazil
Argentina
Peru
Chile
Colombia
Rest of Latin America
Middle East
UAE
KSA
Israel
Turkey
Iran
Rest of Middle East
Africa
Egypt
Nigeria
Algeria
Morocco
Rest of Africa
Regional Analysis
North America Vaccine Delivery Devices Market
The North America Vaccine Delivery Devices Market reached USD 1,764.35 million in 2024 and is projected to hit USD 3,098.19 million by 2032, expanding at a CAGR of 7.3%. It accounted for approximately 23.9% of the global market share in 2024. The United States leads the region with widespread adoption of advanced injection technologies, coupled with government-led immunization initiatives. Strong healthcare infrastructure and a high rate of vaccine acceptance contribute significantly to regional growth. Canada follows with investments in intradermal and microneedle systems, driven by its emphasis on needle-free solutions. Strategic partnerships among biopharma players and medical device manufacturers support innovation in delivery methods.
Europe Vaccine Delivery Devices Market
The Europe Vaccine Delivery Devices Market was valued at USD 1,664.13 million in 2024 and is estimated to reach USD 3,170.93 million by 2032, growing at a CAGR of 8.4%. The region represented 22.5% of the global market share in 2024. Germany, France, and the UK remain central hubs for medical device production and vaccine technology development. It benefits from strong regulatory support and increasing government funding for immunization programs. The rising geriatric population and demand for booster doses create consistent demand for effective and minimally invasive delivery systems. Collaborative research among EU member states also drives innovation across delivery platforms.
Asia Pacific Vaccine Delivery Devices Market
The Asia Pacific Vaccine Delivery Devices Market stood at USD 2,561.50 million in 2024 and is expected to reach USD 4,849.33 million by 2032, advancing at a CAGR of 8.3%. It commanded the highest market share globally at 34.8% in 2024. China, India, and Japan play pivotal roles in production and consumption of delivery devices, driven by large-scale immunization campaigns. Rising healthcare spending, urbanization, and expansion of private healthcare facilities enhance market penetration. It benefits from growing investments in smart injector technologies and mobile vaccination units. Domestic players are increasingly collaborating with global firms to improve device distribution in rural areas.
Latin America Vaccine Delivery Devices Market
The Latin America Vaccine Delivery Devices Market generated USD 728.78 million in 2024 and is forecast to reach USD 1,212.33 million by 2032, with a CAGR of 6.6%. The region accounted for 9.9% of the global market share in 2024. Brazil and Mexico dominate the market due to their proactive immunization drives and rising demand for pediatric vaccine solutions. Public-private collaborations aim to introduce more cost-efficient and less invasive delivery methods. It is witnessing growth in auto-disable syringe adoption to curb contamination risks. Infrastructure development in public health continues to widen the access to vaccination services across underserved communities.
Middle East Vaccine Delivery Devices Market
The Middle East Vaccine Delivery Devices Market reached USD 482.13 million in 2024 and is set to climb to USD 848.63 million by 2032, registering a CAGR of 7.4%. It made up 6.5% of the global market share in 2024. Countries like Saudi Arabia and the UAE are actively upgrading their healthcare systems with innovative delivery tools. It shows increasing preference for prefilled syringes and safety-engineered devices to reduce needle-stick injuries. National immunization schedules and pandemic preparedness strategies are key growth drivers. Government tenders for procurement of advanced vaccine delivery systems are becoming more frequent in the region.
Africa Vaccine Delivery Devices Market
The Africa Vaccine Delivery Devices Market was valued at USD 183.99 million in 2024 and is expected to reach USD 290.96 million by 2032, growing at a CAGR of 5.9%. The region contributed 2.5% of the global market share in 2024. It faces challenges such as limited access to healthcare services and underdeveloped distribution channels. South Africa leads in adoption, supported by NGO partnerships and mobile immunization initiatives. It is gradually integrating auto-disable syringes and thermostable delivery systems in rural areas. Increased international funding is expected to improve access and accelerate deployment of efficient vaccine administration tools.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
The Global Vaccine Delivery Devices Market features a competitive landscape marked by innovation, strategic collaborations, and geographic expansion. Major players such as BD maintain a stronghold through a broad product portfolio and global distribution networks. Emerging companies like PharmaJet and Vaxxas are gaining traction by introducing needle-free and microneedle delivery systems that enhance patient compliance and safety. Schott AG and Gerresheimer AG contribute significantly by supplying high-quality glass and polymer-based containers for vaccine storage and delivery. It fosters competition through continuous R\&D, with companies focusing on device efficiency, safety, and cost-effectiveness. The market remains dynamic, with established firms acquiring or partnering with startups to integrate cutting-edge technologies.
Recent Developments
On January 20, 2025, BD showcased its Evolve On‑body Injector and iDFill RFID‑enabled prefillable syringe systems at Pharmapack 2025 in Paris, highlighting improved ease of use, dose accuracy, and connected capabilities
Market Concentration and Characteristics
The Global Vaccine Delivery Devices Market exhibits moderate to high market concentration, with a few dominant players such as BD, Gerresheimer AG, and PharmaJet holding significant revenue shares. It features a mix of established manufacturers and emerging innovators focusing on advanced technologies like needle-free injectors and microneedle patches. The market is characterized by high regulatory standards, strong demand for safety and precision, and increasing preference for self-administration solutions. Product differentiation, continuous innovation, and global distribution capabilities define competitive strength. It responds quickly to public health needs, pandemic outbreaks, and evolving immunization strategies. Strategic partnerships and R&D investments play a critical role in shaping its future.
Report Coverage
The research report offers an in-depth analysis based on Device Type, Route of Administration and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Needle-free delivery systems such as jet injectors and microneedle patches will gain wider acceptance due to rising demand for painless and safer alternatives to conventional syringes.
Auto-injectors and wearable vaccine delivery devices will see growth as healthcare shifts toward home-based and patient-centric care models.
Smart vaccine delivery devices with dose-tracking features will integrate with electronic health records to enhance monitoring and compliance across healthcare systems.
Manufacturers will focus on eco-friendly materials and recyclable components to reduce medical waste and align with global sustainability goals.
Expanding immunization programs in Asia, Africa, and Latin America will create strong demand for affordable and durable vaccine delivery devices.
Governments and international health agencies will prioritize stockpiling and rapid deployment systems to support emergency vaccination campaigns.
Specialized devices designed for children and elderly patients will become more prevalent, offering improved comfort, safety, and ease of use.
Efforts to harmonize international regulatory standards will speed up approval processes, enabling faster market entry for new devices.
Collaborations between manufacturers, NGOs, and governments will strengthen supply chains and promote equitable access to advanced delivery technologies.
New delivery systems tailored to specific patient profiles and vaccine types will enhance precision, reduce side effects, and improve immunization outcomes.
10.1. Vaccine Delivery Devices Market Overview By Region Segment
10.1.1. Global Vaccine Delivery Devices Market Revenue Share By Region
10.1.2. Regions
10.1.3. Global Vaccine Delivery Devices Market Revenue By Region
10.1.4. Device Type
10.1.5. Global Vaccine Delivery Devices Market Revenue By Device Type
10.1.6. Route of Administration
10.1.7. Global Vaccine Delivery Devices Market Revenue By Route of Administration
CHAPTER NO. 11 : NORTH AMERICA VACCINE DELIVERY DEVICES MARKET – COUNTRY ANALYSIS
11.1. North America Vaccine Delivery Devices Market Overview By Country Segment
11.1.1. North America Vaccine Delivery Devices Market Revenue Share By Region
11.2. North America
11.2.1. North America Vaccine Delivery Devices Market Revenue By Country
11.2.2. Device Type
11.2.3. North America Vaccine Delivery Devices Market Revenue By Device Type
11.2.4. Route of Administration
11.2.5. North America Vaccine Delivery Devices Market Revenue By Route of Administration
11.3. U.S.
11.4. Canada
11.5. Mexico
CHAPTER NO. 12 : EUROPE VACCINE DELIVERY DEVICES MARKET – COUNTRY ANALYSIS
12.1. Europe Vaccine Delivery Devices Market Overview By Country Segment
12.1.1. Europe Vaccine Delivery Devices Market Revenue Share By Region
12.2. Europe
12.2.1. Europe Vaccine Delivery Devices Market Revenue By Country
12.2.2. Device Type
12.2.3. Europe Vaccine Delivery Devices Market Revenue By Device Type
12.2.4. Route of Administration
12.2.5. Europe Vaccine Delivery Devices Market Revenue By Route of Administration
12.3. UK
12.4. France
12.5. Germany
12.6. Italy
12.7. Spain
12.8. Russia
12.9. Rest of Europe
CHAPTER NO. 13 : ASIA PACIFIC VACCINE DELIVERY DEVICES MARKET – COUNTRY ANALYSIS
13.1. Asia Pacific Vaccine Delivery Devices Market Overview By Country Segment
13.1.1. Asia Pacific Vaccine Delivery Devices Market Revenue Share By Region
13.2. Asia Pacific
13.2.1. Asia Pacific Vaccine Delivery Devices Market Revenue By Country
13.2.2. Device Type
13.2.3. Asia Pacific Vaccine Delivery Devices Market Revenue By Device Type
13.2.4. Route of Administration
13.2.5. Asia Pacific Vaccine Delivery Devices Market Revenue By Route of Administration
13.3. China
13.4. Japan
13.5. South Korea
13.6. India
13.7. Australia
13.8. Southeast Asia
13.9. Rest of Asia Pacific
CHAPTER NO. 14 : LATIN AMERICA VACCINE DELIVERY DEVICES MARKET – COUNTRY ANALYSIS
14.1. Latin America Vaccine Delivery Devices Market Overview By Country Segment
14.1.1. Latin America Vaccine Delivery Devices Market Revenue Share By Region
14.2. Latin America
14.2.1. Latin America Vaccine Delivery Devices Market Revenue By Country
14.2.2. Device Type
14.2.3. Latin America Vaccine Delivery Devices Market Revenue By Device Type
14.2.4. Route of Administration
14.2.5. Latin America Vaccine Delivery Devices Market Revenue By Route of Administration
14.3. Brazil
14.4. Argentina
14.5. Rest of Latin America
CHAPTER NO. 15 : MIDDLE EAST VACCINE DELIVERY DEVICES MARKET – COUNTRY ANALYSIS
15.1. Middle East Vaccine Delivery Devices Market Overview By Country Segment
15.1.1. Middle East Vaccine Delivery Devices Market Revenue Share By Region
15.2. Middle East
15.2.1. Middle East Vaccine Delivery Devices Market Revenue By Country
15.2.2. Device Type
15.2.3. Middle East Vaccine Delivery Devices Market Revenue By Device Type
15.2.4. Route of Administration
15.2.5. Middle East Vaccine Delivery Devices Market Revenue By Route of Administration
15.3. GCC Countries
15.4. Israel
15.5. Turkey
15.6. Rest of Middle East
CHAPTER NO. 16 : AFRICA VACCINE DELIVERY DEVICES MARKET – COUNTRY ANALYSIS
16.1. Africa Vaccine Delivery Devices Market Overview By Country Segment
16.1.1. Africa Vaccine Delivery Devices Market Revenue Share By Region
16.2. Africa
16.2.1. Africa Vaccine Delivery Devices Market Revenue By Country
16.2.2. Device Type
16.2.3. Africa Vaccine Delivery Devices Market Revenue By Device Type
16.2.4. Route of Administration
16.2.5. Africa Vaccine Delivery Devices Market Revenue By Route of Administration
16.3. South Africa
16.4. Egypt
16.5. Rest of Africa
CHAPTER NO. 17 : COMPANY PROFILES
17.1. BD
17.1.2. Product Portfolio
17.1.3. Financial Overview
17.1.4. Recent Developments
17.1.5. Growth Strategy
17.1.6. SWOT Analysis
17.2. Pharmajet, Inc.
17.3. Vaxxas
17.4. Schott AG
17.5. Gerresheimer AG
17.6. Corium International, Inc.
17.7. Bioject Medical Technologies, Inc.
17.8. Other Key Players
Request Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What was the market size of the Global Vaccine Delivery Devices Market in 2023, and what is the forecast for 2032?
The market was valued at approximately USD 6,850 million in 2023 and is projected to reach USD 13,470.4 million by 2032, growing at a CAGR of 7.83% from 2025 to 2032.
Which factors are driving the growth of the vaccine delivery devices market?
The market is driven by rising immunization rates, infectious disease outbreaks, technological advancements, and global government support for vaccination programs.
What are the key technologies shaping the vaccine delivery devices market?
Needle-free injectors, microneedle patches, and smart auto-injectors are among the key innovations improving safety, compliance, and administration efficiency.
Which regions are expected to witness the highest market growth?
Asia-Pacific is expected to record the fastest growth due to expanding immunization programs, large populations, and increasing healthcare investments.
Who are the leading players in the Global Vaccine Delivery Devices Market?
Major companies include Becton, Dickinson and Company, 3M Company, PharmaJet, Gerresheimer AG, and Vaxxas, all of which focus on innovation and strategic partnerships.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
Pentavalent Vaccine Market size was valued at USD 2726 million in 2024 and is anticipated to reach USD 4027.5 million by 2032, at a CAGR of 5% during the forecast period.
The combination vaccines market size was valued at USD 5640.1 million in 2024 and is anticipated to reach USD 12,719 million by 2032, growing at a compound annual growth rate (CAGR) of 10.7% during the forecast period.
The Covid vaccine packaging market size was valued at USD 1895 million in 2024 and is anticipated to reach USD 3507.5 million by 2032, at a CAGR of 8 % during the forecast period (2024-2032).
Pneumococcal Conjugate Vaccine (PCV) Market size was valued at USD 8490 million in 2024 and is anticipated to reach USD 13238.42 million by 2032, at a CAGR of 5.71% during the forecast period (2024-2032).
The Vaccine Transport Carrier Market size was valued at USD 2,750 million in 2024 and is anticipated to reach USD 4,094 million by 2032, at a CAGR of 5.1% during the forecast period (2024-2032).
Encephalitis Vaccines Market size was valued at USD 22417.04 million in 2024 and is anticipated to reach USD 40278.79 million by 2032, at a CAGR of 7.6% during the forecast period (2024-2032).
The Seasonal Influenza Vaccines And Therapeutics Market is projected to grow from USD 7,180 million in 2024 to an estimated USD 14,306.59 million by 2032, with a compound annual growth rate (CAGR) of 9% from 2024 to 2032.
The Duck Virus Enteritis Vaccine market is projected to grow from USD 1486.55 million in 2024 to USD 2659.13 million by 2032, at a compound annual growth rate (CAGR) of 7.54%.
The Companion Animal Vaccines Market size was valued at USD 3412 million in 2024 and is anticipated to reach USD 5775.35 million by 2032, at a CAGR of 6.8% during the forecast period (2024-2032).
Purchase Options
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$6999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
